1. Home
  2. CDT

as of 08-27-2026 3:26pm EST

$1.87
$0.02
-1.32%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Founded: 2019 Country:
United States
United States
Employees: N/A City: NAPLES
Market Cap: 2.4M IPO Year: 2022
Target Price: N/A AVG Volume (30 days): 55.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -28.60 EPS Growth: -5637.41
52 Week Low/High: $0.30 - $11.00 Next Earning Date: 04-15-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -0.07 Index: N/A
Free Cash Flow: -15606000.0 FCF Growth: N/A

Share on Social Networks: